GHCPD Webinar: Innovations on Test and Treat Strategies to Improve Outcomes of Malaria in Pregnancy
Global Health Continuing Professional Development (GHCPD) is inviting registration for the webinar on Innovations on Test and Treat Strategies to Improve Outcomes of Malaria in Pregnancy.
Date: June 11, 2024
Time: 11am EDT, 5pm CEST
Post pandemic, as countries try to rebuild healthcare systems with more diagnostic and surveillance capacity and develop more patient-centred approaches to care, we are once more reminded of the importance of breaking down siloed disease control interventions. A recent review estimated that 125 million pregnant women are at risk of contracting malaria, a preventable cause of maternal and infant morbidity and mortality. Malaria in pregnancy is associated with anemia, stillbirth, low birth weight and maternal and fetal death. The 2016 Lancet Stillbirth series showed that malaria and syphilis are the top causes of preventable stillbirths worldwide despite policies for intermittent preventive treatment in pregnancy (IPTp).
On 25th November 2022, the World Health Organization (WHO) updated the guidelines for the treatment of uncomplicated malaria in the first trimester to include artemether-lumefantrine (AL) as the preferred treatment option. Pregnant women treated in the first trimester with AL had a 42% lower risk of adverse pregnancy outcomes than those treated with oral quinine. The safety data from this meta-analysis, together with the superior tolerability and better adherence, higher efficacy, longer duration of post-treatment prophylaxis, and wide availability of ACTs, is the basis for the updated recommendation.
Now is an opportune time to review the evidence on effectiveness of single and intermittent screening and treatment of malaria in pregnancy, as the basis to consider malaria screening in a comprehensive prenatal screening package that traditionally only includes testing for HIV, syphilis, anemia, diabetes, and pre-eclampsia. In this webinar, we will hear from experts and invite you to brainstorm on innovations on test and treat strategies to improve outcomes of malaria in pregnancy.
Objectives:
- Review advances in diagnostic tools to support malaria case detection
- Brainstorm on test and treat strategies to reduce adverse outcomes of malaria in pregnancy
Agenda:
- Welcome – 5 min
- Rosanna Peeling, LSHTM
- Julie Gutman, Chairperson, RBM Malaria in Pregnancy Working Group
- Progress in diagnostic tools to support malaria case detection
- Gonzalo Domingo, PATH – 10min
- Consequences of antenatal malaria infections on pregnancy outcome
- Steve Taylor, Duke University – 10min
- Evidence with test and treat approaches for the control of malaria in pregnancy
- Feiko ter Kuile, LSTM – 10min
- Q&A – 20 min
- Closing – 5min
- Andrea Bosman, WHO
To register, click here.
